Paul M J Mcsheehy - Novartis | 人才画像

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 98 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery and Optimization of Oxidative Phosphorylation Inhibitors from a Phenotypic Screen

Mahmoud El Shemerly, Florian Richalet, Dimitri Robay, Claude Nuoffer, Alexandra Kunz, Luc Bury, Claire Hisler, Norbert Hermann, Jochen Spickermann, Sven Weiler,Paul M J McSheehy,Laurenz Kellenberger,Heidi A Lane

Anti-cancer drugs (2025)

引用0浏览0WOS引用

Dual TTK/PLK1 Inhibition Has Potent Anticancer Activity in TNBC As Monotherapy and in Combination

Elisa Zanini,Nicole Forster-Gross,Felix Bachmann, Adrian Bruengger,Paul Mcsheehy,Karine Litherland,Karin Burger, Anna C. Groner,Mila Roceri, Luc Bury, Martin Stieger,Nicole Willemsen-Seegers,Jos de Man,Diep Vu-Pham, Helma W. E. van Riel,Guido J. R. Zaman,Rogier C. Buijsman,Laurenz Kellenberger,Heidi A. Lane

FRONTIERS IN ONCOLOGY (2024)

引用0浏览0WOS引用

Supplementary Figures S1-S9 from Quantified Tumor T1 is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability

Paul M.J. McSheehy,Claudia Weidensteiner,Catherine Cannet,Stephane Ferretti, Didier Laurent,Stephan Ruetz,Michael Stumm,Peter R. Allegrini

openalex（2023）

引用0浏览0引用

Supplementary Figures 1-3 from Effects of the Dual Phosphatidylinositol 3-Kinase/mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging

Christian R. Schnell,Frédéric Stauffer,Peter R. Allegrini,Terence O'Reilly,Paul M.J. McSheehy,Celine Dartois,Michael Stumm,Robert Cozens,Amanda Littlewood-Evans,Carlos García-Echeverría,Sauveur-Michel Maira

crossref（2023）

引用0浏览0引用

Derazantinib, a Fibroblast Growth Factor Receptor Inhibitor, Inhibits Colony-Stimulating Factor Receptor-1 in Macrophages and Tumor Cells and in Combination with a Murine Programmed Cell Death Ligand-1-antibody Activates the Immune Environment of Murine Syngeneic Tumor Models

Mahmoud El Shemerly,Elisa Zanini,Marc Lecoultre,Paul R. Walker,Laurenz Kellenberger,Heidi A. Lane,Paul M. J. Mcsheehy

ANTI-CANCER DRUGS（2023）

引用0浏览0WOS引用

Supplementary Figures S1-S4 from Mtor Inhibitor RAD001 (everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

Heidi A. Lane,Jeanette M. Wood,Paul M.J. McSheehy,Peter R. Allegrini,Anne Boulay,Joseph Brueggen,Amanda Littlewood-Evans,Sauveur-Michel Maira,Georg Martiny-Baron,Christian R. Schnell,Patrizia Sini,Terence O'Reilly

openalex（2023）

引用0浏览0引用

Supplementary Figure 4 from Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma

Anne-Christine Piguet,Bettina Saar,Ruslan Hlushchuk,Marie V. St-Pierre,Paul M.J. McSheehy, Vesna Radojevic, Maresa Afthinos, Luigi Terracciano, Valentin Djonov, Jean-François Dufour

openalex（2023）

引用0浏览0引用

Supplementary Tables S1-S6 from Quantified Tumor T1 is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability

Paul M.J. McSheehy,Claudia Weidensteiner,Catherine Cannet,Stephane Ferretti, Didier Laurent,Stephan Ruetz,Michael Stumm,Peter R. Allegrini

openalex（2023）

引用0浏览0引用

Derazantinib, an FGFR1-3 Inhibitor, Inhibits CSF1R in Macrophages and Tumor Cell Lines, and Synergizes with a PDL1-antibody in an FGFR-driven Murine Syngeneic Model

Mahmoud El Shemerly,Laurenz Kellenberger,Elisa Zanini,Heidi Lane,Paul McSheehy

Cancer Researchno. 12_Supplement (2022): 5501-5501

引用0浏览0引用

BAL0891: A Novel, Small Molecule, Dual TTK/PLK1 Mitotic Checkpoint Inhibitor (MCI) That Drives Aberrant Tumor Cell Division

Elisa Zanini,Nicole Forster-Gross,Felix Bachmann,Nicole Willemsen-Seegers,Jos de Man,Guido J. Zaman,Rogier C. Buijsman, Anna Groner,Mila Roceri,Karin Burger,Paul McSheehy,Laurenz Kellenberger,Heidi A. Lane

Cancer Researchno. 12_Supplement (2022): 5646-5646

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn